Author:
Adair Frank E.,Herrmann Julian B.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial;The Lancet Oncology;2024-03
2. Revisiting Androgen Receptor Signaling in Breast Cancer;The Oncologist;2023-03-27
3. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review;Molecular and Cellular Endocrinology;2021-07
4. Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer;Molecular Aspects of Medicine;2021-04
5. DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER;Siberian journal of oncology;2021-03-06